Mandeep Singh, M.B.B.S., M.D., Ph.D., an assistant professor of ophthalmology, Wilmer Eye Institute, is one of 2022's grantees of the Louis B. Thalheimer Fund for Translational Research for his work "Cytoplasmic Transfer Cell Therapy for Vision Repair in Retinitis Pigmentosa." The Thalheimer Fund, administered through Johns Hopkins Technology Ventures, provides seed funding for vital proof-of-concept and validation studies of Johns Hopkins technologies.